Orchard Therapeutics
Orchard Therapeutics51About
What does Orchard Therapeutics do?
Orchard Therapeutics is a gene therapy company focused on developing and commercializing HSC gene therapy for severe and other genetic diseases. They aim to transform the lives of people living with these conditions, building on decades of research to apply their platform to areas of significant medical need. The company shares stories and experiences of families impacted by diseases like metachromatic leukodystrophy to motivate their mission.
What is Orchard Therapeutics's revenue?
StartupHub estimates Orchard Therapeutics's annual revenue at $76.5M (range $41.9M to $136.6M, 64% confidence), based on comparable companies in the sector.
What is Orchard Therapeutics's valuation?
StartupHub estimates Orchard Therapeutics's effective valuation at $482.4M (range $312.5M to $750.0M, 10% confidence), based on comparable companies in the sector.
How much funding has Orchard Therapeutics raised?
Orchard Therapeutics has raised a total of $125M in funding. The most recent round on record is IPO.
Where is Orchard Therapeutics headquartered?
Orchard Therapeutics is headquartered in Boston, United States.
When was Orchard Therapeutics founded?
Orchard Therapeutics was founded in 2015.
What industry does Orchard Therapeutics operate in?
Orchard Therapeutics operates in Biotech, MedTech, HealthTech, Genomics, Drug Discovery, Clinical Trials.
How many employees does Orchard Therapeutics have?
Orchard Therapeutics has approximately 248 people on record.
No comments yet. Be the first to share your take.